FDA Updates Opioid Labels to Emphasize Long-Term Risks

New labeling rules follow evidence linking extended opioid use to serious health dangers, including addiction and overdose. The U.S. Food and Drug Administration (FDA) has mandated updated safety…

Read More

HHS Secretary and CMS Administrator Commit to Prior Authorization Reforms

They announced major private-sector pledges to reduce delays and burdens in health coverage approvals. Health and Human Services (HHS) Secretary Robert F. Kennedy, Jr. and Centers for Medicare…

Read More

FDA Expands Approval for RSV Vaccine for Adults Under 60

Without a CDC director, the approval depends on the HHS secretary to endorse it. The Food and Drug Administration (FDA) approved the use of Moderna’s Respiratory Syncytial Virus…

Read More

FWS Recommends Endangered Species Designation for Pangolin

The agency says the small scaly mammal is “the most trafficked mammal in the world.” The U.S. Fish and Wildlife Service (FWS) proposed improved protections for pangolins this…

Read More

FTC Challenges Drug Patents Hindering Generic Competition

The agency renewed efforts to remove over 200 disputed patents from FDA’s Orange Book to promote affordable medication access. The Federal Trade Commission (FTC) recently renewed its challenge…

Read More

HHS Issues Report from President’s MAHA Commission

The health secretary says policy recommendations will be issued over the next 100 days. The Department of Health and Human Services (HHS) released a preliminary health assessment last…

Read More

HHS Releases Review of Medical Interventions for Gender Dysphoria in Minors

The evidence increasingly shows significant risks of irreversible harm from puberty blockers, cross-sex hormones, and surgery. The Department of Health and Human Services released a comprehensive review this…

Read More

FDA Approves Qfitlia for Hemophilia Treatment

New medication offers less frequent doses to reduce bleeding episodes in patients with Hemophilia A and B. The U.S. Food and Drug Administration has recently approved Qfitlia (fitusiran)…

Read More

State Department Cuts $60+ Billion in Wasteful Spending

Secretary Rubio has retained programs that met specific criteria and support U.S. interests. The State Department has saved $60 billion in taxpayer funding after thoroughly reviewing all grants…

Read More

HHS Secretary Launches Review of Childhood ADHD, Depression Medication

He claims that medications have been overprescribed. Secretary of Health and Human Services (HHS) Robert F. Kennedy, Jr. has made prescriptions for childhood chronic diseases, like attention-deficit/hyperactivity disorder…

Read More

Back to top
FE3